coronaviruses such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERSCoV), HCoV-NL63, and HCoV-HKU1. [5] [6] [7] [8] [9] There is currently no effective vaccine or therapeutic reagent against most of these respiratory viruses, except for the influenza viruses. Therefore, continuous laboratory monitoring is required to predict future epidemics and prevent a public health threat.
The Korea Centers for Disease Control and Prevention (KCDC) has been running a surveillance system to detect the major 
| MATERIALS AND METHODS

| Specimen and clinical data collection
| RT-PCR
| Statistical analysis
The analysis was performed through multivariate logistic regression analysis to identify the association between each virus and clinical symptoms or age groups. Odds ratios (ORs) and their 95% confidence intervals (CIs) were estimated using maximum-likelihood methods. All statistical analyses were conducted using SPSS ver. 23. 0 (SPSS Inc., Chicago, IL).
| RESULTS
| Prevalence of respiratory viruses
Of the 36 915 nasal aspirate and throat swab samples 18 236 (49.4%)
were positive for at least one respiratory virus ( Figure 1A) . The monthly positive rates ranged from 28.2% to 76.5% ( Figure 1B) However, HMPV had the lowest co-detection rate. Co-detection were significantly more frequent in children and adolescents (1-19 years old) than in the <1 and ≥20-year-old age groups (data not shown).
| Clinical symptoms
Most of the respiratory virus infections were significantly associated with fever, cough, and runny nose, except for HAdV. However, HCoV and HRV infections were less commonly correlated with fever and a few of the HRSVs-infected patients showed diarrhea. As expected,
IFVs infection resulted in influenza-like illness (ILI) such as sore throat, chills, headache, and myalgia (Table 1) in most of the patients.
| Seasonality of respiratory virus
The seasonal distribution of the eight respiratory viruses is shown in ( Figure 2C ).
Among the HCoVs identified, HCoV-OC43 and HCoV-NL63 were the most frequent, with a few cases of infections with HCoV-229E.
HCoV-OC43 and HCoV-NL63 were prevalent in winter of 2013 and 2014, respectively ( Figure 2D ).
The prevalence of IFV infections began to increase in early winter, and peaked between January and March. Among IFV A, H3N2 virus was more predominantly detected compared to H1N1pdm09 virus.
Moreover, the incidence of IFV B increased, followed by a peak of IFV A in 2014 and 2105 ( Figure 2E ).
| Distribution of respiratory viruses according to age groups
The patients ranged from <1 to 95 years of age and were classified into six age groups. Most of the respiratory viruses identified mainly occurred in infants and children under 5 years of age. Although IFVs and HRV were detected most frequently for all age groups, IFV infections were particularly more prevalent in school children and adolescents between 6 and 19 years of age. Moreover, HCoV infections were evenly distributed across all age groups, unlike the other viruses (Table 2) . However, these results do not represent all of the known respiratory viruses responsible for ARI, moreover currently unknown or undetected viruses may also be circulating in Korea to cause ARI.
HRV and IFVs were the most frequently identified viruses in the three years, and the detection rates of other viruses ranged from 3.6% to 7.5%, except for HBoV and HMPV, which showed positive rates below 2%. Our results are similar to previous studies. 12, 13 Most of the identified respiratory viruses in this study caused the typical clinical symptoms of ARI. In contrast to other viral infections, IFVs infection resulted in apparent ILI symptoms, including sore throat, chills, headache, and myalgia, as described previously.
14 Analysis of the seasonal prevalence patterns of each respiratory virus is useful for improving diagnosis and developing effective prevention and quarantine strategies. Similar to previous reports, most of the viruses showed seasonality except for HRV and HAdV, which occurred throughout the year. 2 IFV type A, including the strains H1N1 pdm09 and H3N2, and IFV type B were most prevalent between December and April, and the incidence of type B increased followed by type A. Previous studies have suggested that HBoV infections occur during the winter and increase in the spring and summer. 15 However, HBoV mainly detected from April to July, similar to another study reported in Korea. 11 This suggests that HBoV may show a regionally specific prevalence pattern. During the study period, cases of HMPV detection were relatively rare throughout the year, but were mainly identified in the spring with a high peak in April 2014. Which is similar to other reports and HRSVs were mainly detected in the fall and early winter before the IFVs epidemic. [16] [17] [18] HPIVs showed different prevalence and seasonality patterns depending on the subtype. HPIV 1 circulated throughout the year and HPIV 3 was prevalent between spring and summer. However, HPIV 2 was rarely detected throughout the year and did not show an annual seasonal pattern, consistent with reports from China and Japan. 19, 20 Although the incidence of HCoV-OC43 and HCoV-229E is higher in the winter in temperate regions, the trend for HCoV-NL63 prevalence also shows geographical variation; for example, it mainly occurs in the winter in the Netherlands but is predominant in the spring and summer in Hong Kong. 21, 22 In this study, HCoV-NL63 was mainly detected in the winter with a maximum peak in 2014 and the highest HCoV-OC43 incidence was showed tended to be higher in winter in 2013. However, the seasonality of HCoV-229E could shown a predominance in infants and young children, 15, 17, 19 which was confirmed in the present study. In line with previous studies, the rate of detection for HAdV was highest in young children under the age of five and peaked between the 1 and 5-year age group; HCoVs, HRV, and IFVs were detected across all age groups and HCoVs were frequently detected in elderly adults. 4, 8, 16, 23 IFV infection was predominant detected in children over 6 years old and peaked in the 6-19-year-old group, indicating a higher risk of infection in schools.The prevalence of respiratory virus co-detection in infants and young children, in whom viral shedding in the respiratory tract is usually high, has been reported to be higher than that in adults, 12, 24, 25 although the clinical symptoms associated with cases of co-detection are currently unclear. Consistently, co-detection was more frequent
in young children and adolescents in this study. Despite the low HBoV detection rate, it showed a high (53.3%) co-infection rate compared to that of the other viral agents, which is also in accordance with other studies. 11, 26 This result is probably attributed to its long shedding period of HBoV containing a DNA genome. In some studies, co-infections of HRSV and other viruses were found at a relatively higher incidence of nearly 40%, and multi-infection cases with or without clinical differences were associated with a longer duration of hospitalization compared to cases of single infection. 24, 25 However, the codetection rate for HRSV was approximately 20% in this study, its clinical relevance is uncertain. IFVs showed a relatively low codetection rate, which might be associated with its distinct seasonal prevalence and age distribution from those of the other viruses.
Taken together, these results should be useful for predicting future trends and could help to prevent outbreaks. However, longterm surveillance studies are needed to conduct a more in-depth analysis of the relationship between the epidemiology of respiratory virus infections and typical manifestations of known clinical outcomes, which would be helpful for the management of patients with ARIs.
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